 VANCOUVER, Wash.--BUSINESS WIRE--The Board of Directors the Board of CytoDyn Inc. OTCQB: CYDY CytoDyn or the Company, a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the resolution of its lawsuit the Federal Lawsuit brought in the United States District Court for the District of Delaware against the activist group led by Paul Rosenbaum and Bruce Patterson the RosenbaumPatter 